235 related articles for article (PubMed ID: 8573743)
1. Advanced glycation endproducts and diabetic nephropathy.
Makita Z; Yanagisawa K; Kuwajima S; Yoshioka N; Atsumi T; Hasunuma Y; Koike T
J Diabetes Complications; 1995; 9(4):265-8. PubMed ID: 8573743
[TBL] [Abstract][Full Text] [Related]
2. 'Toxicity of glucose: is AGE the answer?'.
Makita Z
Nephrol Dial Transplant; 1995; 10 Suppl 7():33-7. PubMed ID: 8570076
[TBL] [Abstract][Full Text] [Related]
3. Clinical studies of advanced glycation end product inhibitors and diabetic kidney disease.
Williams ME
Curr Diab Rep; 2004 Dec; 4(6):441-6. PubMed ID: 15539009
[TBL] [Abstract][Full Text] [Related]
4. Advanced glycation end products and diabetic nephropathy.
Thomas MC; Forbes JM; Cooper ME
Am J Ther; 2005; 12(6):562-72. PubMed ID: 16280650
[TBL] [Abstract][Full Text] [Related]
5. Role of AGEs in diabetic nephropathy.
Fukami K; Yamagishi S; Ueda S; Okuda S
Curr Pharm Des; 2008; 14(10):946-52. PubMed ID: 18473844
[TBL] [Abstract][Full Text] [Related]
6. The importance of diabetic nephropathy in current nephrological practice.
Locatelli F; Canaud B; Eckardt KU; Stenvinkel P; Wanner C; Zoccali C
Nephrol Dial Transplant; 2003 Sep; 18(9):1716-25. PubMed ID: 12937216
[TBL] [Abstract][Full Text] [Related]
7. Advanced glycation end-products in diabetic nephropathy.
Friedman EA
Nephrol Dial Transplant; 1999; 14 Suppl 3():1-9. PubMed ID: 10382974
[TBL] [Abstract][Full Text] [Related]
8. Advanced glycation end products (AGEs) and diabetic vascular complications.
Yamagishi S; Nakamura K; Imaizumi T
Curr Diabetes Rev; 2005 Feb; 1(1):93-106. PubMed ID: 18220586
[TBL] [Abstract][Full Text] [Related]
9. Aminoguanidine prolongs survival in azotemic-induced diabetic rats.
Friedman EA; Distant DA; Fleishhacker JF; Boyd TA; Cartwright K
Am J Kidney Dis; 1997 Aug; 30(2):253-9. PubMed ID: 9261037
[TBL] [Abstract][Full Text] [Related]
10. Pimagedine: a novel therapy for diabetic nephropathy.
Abdel-Rahman E; Bolton WK
Expert Opin Investig Drugs; 2002 Apr; 11(4):565-74. PubMed ID: 11922864
[TBL] [Abstract][Full Text] [Related]
11. Interactions between advanced glycation end-products (AGE) and their receptors in the development and progression of diabetic nephropathy - are these receptors valid therapeutic targets.
Sourris KC; Forbes JM
Curr Drug Targets; 2009 Jan; 10(1):42-50. PubMed ID: 19149535
[TBL] [Abstract][Full Text] [Related]
12. Advanced glycation end products.
Thomas MC
Contrib Nephrol; 2011; 170():66-74. PubMed ID: 21659759
[TBL] [Abstract][Full Text] [Related]
13. Pathogenetic mechanisms of diabetic nephropathy.
Schena FP; Gesualdo L
J Am Soc Nephrol; 2005 Mar; 16 Suppl 1():S30-3. PubMed ID: 15938030
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms of diabetic nephropathy and its therapeutic intervention.
Yamagishi S; Fukami K; Ueda S; Okuda S
Curr Drug Targets; 2007 Aug; 8(8):952-9. PubMed ID: 17691932
[TBL] [Abstract][Full Text] [Related]
15. Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts.
Thornalley PJ
Arch Biochem Biophys; 2003 Nov; 419(1):31-40. PubMed ID: 14568006
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in understanding the biochemical and molecular mechanism of diabetic nephropathy.
Sun YM; Su Y; Li J; Wang LF
Biochem Biophys Res Commun; 2013 Apr; 433(4):359-61. PubMed ID: 23541575
[TBL] [Abstract][Full Text] [Related]
17. Hyperglycemia to nephropathy via transforming growth factor beta.
Garud MS; Kulkarni YA
Curr Diabetes Rev; 2014 May; 10(3):182-9. PubMed ID: 24919657
[TBL] [Abstract][Full Text] [Related]
18. Progression of nephropathy in spontaneous diabetic rats is prevented by OPB-9195, a novel inhibitor of advanced glycation.
Nakamura S; Makita Z; Ishikawa S; Yasumura K; Fujii W; Yanagisawa K; Kawata T; Koike T
Diabetes; 1997 May; 46(5):895-9. PubMed ID: 9133561
[TBL] [Abstract][Full Text] [Related]
19. Assessing glycemic control in diabetic patients with severe nephropathy.
Robinson TW; Freedman BI
J Ren Nutr; 2013 May; 23(3):199-202. PubMed ID: 23510670
[TBL] [Abstract][Full Text] [Related]
20. Diabetic nephropathy--what have we learned in the last three decades?
Odoni G; Ritz E
J Nephrol; 1999; 12 Suppl 2():S120-4. PubMed ID: 10688411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
